Search Results
Aug 26, 2026, 08:32 ET EvCap Investments and Point Acquisitions Acquire North Phoenix Retail Center
new leasing program, we see substantial opportunity to enhance the property's appeal and performance.""This transaction stood out to us as a rare opportunity to acquire an off-market, value-add center in this emerging North Phoenix submarket," said Jesse Shemesh, President of Point Acquisitions.Ownership
More news about: Point Acquisitions LLC
Aug 26, 2026, 08:00 ET AVAIO Digital Welcomes Teresa Tsung as Vice President of Project Controls, Adding Rare Depth Across Both Hyperscale Data Center Delivery and Power Infrastructure
multimedia:https://www.prnewswire.com/news-releases/avaio-digital-welcomes-teresa-tsung-as-vice-president-of-project-controls-adding-rare-depth-across-both-hyperscale-data-center-delivery-and-power-infrastructure-302859944.htmlSOURCE
More news about: AVAIO Digital
Aug 26, 2026, 08:00 ET Solace Announces Appointment of Mike Capone to Board of Directors
senior leadership positions at ADP."Mike and I developed a strong relationship during his tenure as CEO of Qlik, and I have seen firsthand his rare combination of technology expertise, enterprise perspective, and operating leadership," said Denis King, President and CEO of Solace. "His experience
More news about: Solace Corporation
Aug 26, 2026, 08:00 ET Solace Announces Appointment of Mike Capone to Board of Directors
senior leadership positions at ADP."Mike and I developed a strong relationship during his tenure as CEO of Qlik, and I have seen firsthand his rare combination of technology expertise, enterprise perspective, and operating leadership," said Denis King, President and CEO of Solace. "His experience
More news about: Solace Corporation
Aug 26, 2026, 08:00 ET Ministry of Food and Drug Safety of Korea, Accelerates the Pace of Innovation for the Great Leap in Bio
KAIST), Jeremy Farrar (Assistant Director-General, World Health Organization), Azad Bonni (Senior Vice President and Global Head of Neuroscience and Rare Diseases, Roche pRED) and David Nogales (Head of Technology Strategy, Merck KGaA), among other leading scholars from Korea and abroad, as well as experts
More news about: The Korea Herald
Aug 26, 2026, 07:00 ET Insmed to Present at September 2026 Investor Conferences
commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology & Inflammation, and Neuro & Other Rare. The Company's research engine is advancing a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, RNA end-joining,
More news about: Insmed Incorporated
Aug 26, 2026, 07:00 ET Giving Tree Surrogacy Launches Family Forward Guarantee™, a Fixed-Cost Surrogacy Program With a Published Match-Time Commitment and a Baby Guarantee via Agency Fee Refund
combination of a fixed cost, a published match-time range, and a contractual guarantee is what most influences their choice of program — because it is rare to find a program that combines all three benefits together in the market. "What sets the Family Forward Guarantee™ apart isn't one feature
More news about: Giving Tree Surrogacy
Aug 26, 2026, 07:00 ET Vivace Therapeutics Strengthens Leadership Team as It Prepares to Advance VT3989, the First TEAD Inhibitor to enter Phase 3 Clinical Trials, as the Leading Treatment for Mesothelioma
compelling, and VT3989 translates that potential into a derisked first-in-class asset with substantial clinical data," said Tim Clackson, PhD "Vivace has a rare opportunity to bring a truly differentiated medicine to patients, and I look forward to working with Craig, Ellen, and the rest of the team as the company
More news about: Vivace Therapeutics, Inc.
Aug 26, 2026, 07:00 ET Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare diseases — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies,
More news about: Jazz Pharmaceuticals plc
Aug 26, 2026, 07:00 ET HUMAN CLINICAL STUDY FINDS SOURSOP JUICE CONSUMPTION SIGNIFICANTLY LOWERS BLOOD PRESSURE AND SERUM URIC ACID
diagnosed with gout, and additional clinical research is necessary before conclusions can be made regarding soursop as a treatment for gout.A RARE HUMAN CLINICAL STUDY OF SOURSOP FRUIT JUICEThe significance of the research extends beyond its findings. The researchers noted that despite
More news about: SOPREME Soursop
Aug 26, 2026, 02:36 ET Biohaven and SK Biopharmaceuticals Enter into Strategic Global Licensing Agreement for Novel Kv7 Ion Channel Platform and Opakalim, Lead Candidate for Epilepsy
Biohaven innovation, from our MoDE and TRAP extracellular protein degraders in immunology to our programs in neuroscience, metabolic conditions, and rare diseases. We are building a diversified, self-sustaining engine for long-term value creation."Summary of Financial TermsNear-Term
More news about: Biohaven Ltd.
Aug 26, 2026, 00:00 ET TIER IV to showcase integrated AI, data, and computing solution for SDVs at Automotive World 2026
autonomous driving AI models.To improve the accuracy of autonomous driving AI models, TIER IV supplements difficult-to-collect driving data, such as rare scenarios directly associated with collision risks and data from adverse weather conditions, with synthetic data generated using NVIDIA Cosmos. The
More news about: TIER IV, Inc.
Aug 25, 2026, 21:24 ET Caliway's CBL-514 Combination Therapy Cleared by U.S. FDA for Phase 2 Trial; Pivotal Phase 3 Trial SUPREME-01 Initiates Enrollment
reduction and moderate-to-severe cellulite. A separate formulation, designated as CBL-514D, is being developed for the treatment of Dercum's Disease, a rare disease. To date, more than 544 subjects have participated in clinical trials related to CBL-514. Across the 10 completed clinical trials with finalized
More news about: Caliway Biopharmaceuticals
Aug 25, 2026, 14:40 ET Women Leaders Association Names Dr. Megan Laabs as First Washington Coaching Partner, Bringing Brain Science to Executive Coaching for the Region's Women Professionals
book a consultation with confidence, have a great experience, and keep rising in their careers.Dr. Laabs brings a background that is genuinely rare in executive coaching. A clinical neuropsychologist and ICF Professional Certified Coach whose practice motto is "High-Performance Leadership, Backed
More news about: Women Leaders Association
Aug 25, 2026, 14:00 ET Primero Launches as the AI Transformation Company for Latin America
Informatics (IOI), or International Collegiate Programming Contest (ICPC)."José, Andrés, and Santiago combine deep technical ambition with a rare understanding of how to build enduring companies in Latin America," said Alex Tran, Managing Director at General Catalyst. "As enterprises across the
More news about: Primero
Aug 25, 2026, 13:19 ET Laboratoires Pierre Fabre Appoints Nicolas Zombré CEO of U.S. Dermocosmetics Business, Signaling Next Phase of Growth
Eau Thermale Avène, Dexeryl, Ducray, Klorane, A-Derma, René Furterer, Même Cosmetics, Darrow, and Elgydium. The Pharma activity covers 5 main therapeutic fields: oncology, dermatology, rare diseases, primary care and family health care.In 2025, Laboratoires Pierre Fabre generated €3.2 billion euros in revenue, 71% of which
More news about: Laboratoires Pierre Fabre
Aug 25, 2026, 12:38 ET Stowers Institute expands Artificial Intelligence Initiative, appoints second AI Fellow
apply advanced computational methods to large and complex datasets from genomics, structural biology, and other areas of research."Charles has a rare ability to bridge computational innovation with fundamental biological questions," said Zeitlinger. "He not only develops powerful AI tools but also
More news about: Stowers Institute for Medical Research
Aug 25, 2026, 12:25 ET OmicsBank Raises $2.25M to Expand Clinical Data Infrastructure Globally for Healthcare, Life Sciences, and Frontier AI Labs
OmicsBank demands, where progress depends on earning the trust of hospitals one institution at a time. That combination of speed and operating judgment is rare, and it's what gave us the conviction to invest.""Making medical and pharmaceutical research more representative of emerging-market populations
More news about: Redesign Health; OmicsBank
Aug 25, 2026, 12:23 ET From Endangered Dragonflies to Oyster Reefs, CITGO's Caring For Our Coast Grants Put $620,000 to Work
The Forest Preserve District of Will County — Lemont, Ill. — $40,000Restores 127.3 acres of globally rare dolomite prairie at Romeoville Prairie Nature Preserve, home to the federally endangered Hine's emerald dragonfly, near the CITGO Lemont Refinery.Galveston
More news about: CITGO Petroleum Corporation
Aug 25, 2026, 11:48 ET HIGH STAKES BY BARTOLOTTA TO OPEN THURSDAY, SEPT. 17, 2026
potato coins with Kaviari caviar and chive blossoms.Premium Shellfish & CrustaceansLangoustines: Rare and unique crustaceans sourced from Chef Bartolotta's dear friend in an undisclosed location.King Crab: Deep-water, trap-caught true
More news about: The Bartolotta Restaurants
Aug 25, 2026, 11:16 ET ketteQ Names Jennie Vandegrift Chief Customer Officer to Lead Global Customer Delivery and Success as Company Scales
ketteQ at such an exciting phase of the company's growth journey," said Jennie Vandegrift, Chief Customer Officer, ketteQ. "The team has built something rare: a track record of 100% successful customer deployments, now being supercharged by Quintus™, our Free-Range AI™. I'm looking forward to partnering with
More news about: ketteQ Holdings Inc.
Aug 25, 2026, 11:00 ET New Study Dates Rare Mars Meteorite to 1.2 Billion Years Old
multimedia:https://www.prnewswire.com/news-releases/new-study-dates-rare-mars-meteorite-to-1-2-billion-years-old-302859529.htmlSOURCE
More news about: Universities Space Research Association
Aug 25, 2026, 11:00 ET New Frontier Minerals Prospectivity Analysis Across Company's NWQ Copper Tenement Package Identifies Eldorado as High Priority for Follow-up Alongside New Frontier's Flagship Big One Deposit
required to power a more electrified and sustainable future. The company holds a strategic portfolio of rare earth, niobium and copper assets in Australia and Canada, which includes the harts Range Heavy Rare Earths and Niobium Project in the Northern Territory, and the NWQ Cooper Project in Queensland. Other
More news about: New Frontier Minerals
Aug 25, 2026, 11:00 ET Blood Cancer United Launches 2026 Light The Night Season During Blood Cancer Awareness Month
Lennox, who was diagnosed at just eight-months-old with multifocal single-system Langerhans cell histiocytosis (LCH), a rare type of blood cancer. He eventually entered a clinical trial and completed treatment this past December. Now three years old, Lennox is doing well and
More news about: BLOOD CANCER UNITED, INC.
Aug 25, 2026, 10:15 ET Peptide Synthesis Market worth $1.54 billion by 2031 - Exclusive Report by MarketsandMarkets™
Market by Offerings (Synthesis products [Consumables, Equipment], Synthesized Oligos (Type [DNA, RNA], Oligo-based Drugs (Type [ASO, siRNA), Therapy Area [Rare Diseases, Neurology, Oncology], Competition - Global Forecast to 2031
More news about: MarketsandMarkets